Uterine papillary serous carcinoma (pure and mixed type) compared with moderately and poorly differentiated endometrioid carcinoma. A clinicopathologic study

Objective: The aim of this study was to investigate the clinicopathologic features and the outcome in patients with pure and mixed type uterine papillary serous carcinoma (UPSC), and to compare these parameters with those observed in patients with moderately and poorly differentiated endometrioid endometrial carcinoma (MPD-EEC).

Methods: The charts of 34 patients with UPSC and 30 patients with MPD-EEC, operated on between January 1995 and December 2000, were retrospectively reviewed. The UPSC group included ten cases of pure and 24 cases of mixed type UPSC (admixed with endometrioid component). All patients had undergone full surgical staging. Clinical features, surgicopathological findings, recurrence rate and recurrence-free interval were compared between the study groups.

Results: Significantly more patients with MPD-EEC than with UPSC were operated on in FIGO stage I and II (p = 0.001). MPD-EEC patients were significantly older and more obese (p = 0.03 and p = 0.01, respectively) as compared with the UPSC patients. Significantly more patients with MPD-EEC presented with postmenopausal bleeding (p = 0.02), had a second primary cancer in the past (p = 0.03) and had a first degree relative with history of malignant disease (p = 0.0001). Conversely, the rates of positive abdominal cytology and cervical involvement were significantly higher in the group of UPSC (p = 0.02 and p = 0.02, respectively). Significantly more patients with UPSC were treated with adjuvant therapy (p = 0.01). No significant difference between the two study groups was observed comparing the recurrence rate, the recurrence free interval and the 3-year survival. There was also no significant difference between the pure and the mixed type UPSC, considering the clinical features and the follow-up data.

Conclusion: The current study presented no significant difference in the outcome of MPD-EEC as compared with the pure and the mixed type UPSC, yet prospective studies are needed to evaluate the role of adjuvant therapy in each study group.

Uterine papillary serous carcinoma; Moderately and poorly differentiated endometrioid endometrial carcinoma; Clinicopathological findings; Survival

[1] Hendrickson M., Ross J., Martinez A., Eifel P., Kempson R.: "Uterine papillary serous carcinoma: a highly malignant form of endometrial adenocarcinoma". Am. J. Surg. Pathol., 1982, 6, 93.

[2] Sutton G. P., Brill L., Michael H., Stehmann F. B., Ehrlich C. E.: "Malignant papillary lesions of the endometrium". Gynecol. Oneal., 1987, 6, 294.

[3] Chambers J. T., Merino M., Kohom E. I., P eschel R. E., Schwarts P. E.: " Uterine papillary serous carcinoma". Obstet. Gynecol., 1987, 69, 109

[4] Rosenberg P., Blom R., Hogberg T., Simonsen E.: "Death rate and recurrence pattern among 841 clinical stage I endometrial cancer patients with special reference to uterine papillary serous carcinoma". Gynecol. Oncol., 1993, 51, 311.

[5] Gitsch G., Friedlander M. L., Wain G. Y., Hacker N. F.: "Uterine papillary serous carcinoma. A clinical study". Cancer, 1995, 75, 2239.

[6] Gallio H. H., van Nagell J. R., P owell D. F., Donaldson E. S., Higgins R. Y., Kryscio R. J. et al.: "Stage I serous papillary carcinoma of the endometrium". Cancer, 1989, 63, 2224.

[7] O'Hanlan K. A., Levine P.A., Harbatkin D., Feiner C., Golberg G L., Jones J. G. et al.: " Virulence of papillary endometrial carcinoma". Gynecol. Oneal., 1990, 37, 112.

[8] Carcangiu M. L., Chambers J. T.: "Uterine papillary serous carcinoma. A study of 108 cases with emphasis on the prognostic significance of associated cndometrioid carcinoma, absence of invasion, and concomitant ovarian carcinoma". Gynecol. Oneal, 1992, 47, 298.

[9] Sherman M. E., Bitterman P., Rosenshein N. B., Delgado G., Kurman R. J.: "Uterine serous carcinoma, a morphologically diverse neoplasm with unifying clinicopathologic features". Am. J Surg. Pathol., 1992, 16, 600.

[10] Kurman R. J., Zaino R. J., Norris H.J.: "Endometrial carcinoma" in Blaustein's Pathology of the Female Genital Tract. Kurman R. J. (ed.), Springer-Verlag, New York, 4"'ed., 1994, 439.

[11] Cirisano F. D., Robboy S. J., Dodge R. K., Bentley R. C., Kngman H. R., Synan I. S. et al.: "Epidemiologic and surgicopathologic findings of papillary serous and clear cell endometrial cancers when compared to endometrioid carcinoma". Gynecol. Oneal., 1999, 74, 385.

[12] Lee K. R., Belinson J. L.: "Recurrence in noninvasive endometrial carcinoma: relationship to uterine papillay serous carcinoma". Am J. Surg. Pathol., 1991, 15, 965.

[13) Nicklin J. L., Copeland L. J.: "Endometrial papillary serous carcinoma: patterns of spread and treatment". Clin. Obstet. Gynecol., 1996, 39, 686.

[14] Carcangiu M. L., Chambers J. T.: "Early pathological stage clear cell carcinoma and uterine papillary serous carcinoma of the endometri um: comparison of clinicopathological features and survival". Int. J. Gynecol. Pathol., 1995, 14, 30.

[15] Shepherd J. H.: "Revised FIGO staging for gynaecological cancer". Br. J. Obstet. Gynecol., 1989, 96, 889.

[16] Goff B. A., Kato D., Schmidt R. A., Ek M., Ferry J. A., Muntz H G. et al.: "Uterine papillary serous carcinoma: patterns of metastatic spread". Gynecol. Oncol., 1994, 54, 264.

[17] Kato D. T., Ferry J. A., Goodman A., Sullinger J., Scully R. E., Goff B. A. et al.: "Uterine papillary serous carcinoma (UPSC): a clinicopathologic study of 30 cases". Gynecol. Oncol., 1995, 59, 384.

[18] Geisler J.P., Geisler H. E., Melton M. E., Wiemann M. C.: "What staging surgery should be performed on patients with uterine papillary serous carcinoma?". Gynecol. Oncol., 1999, 74, 465.

[19] Williams K. E., Waters E. D., Woolas R. P., Hammond I. G., McCamey A. J.: "Mixed serous-endometrioid carcinoma of the uterus: pathologic and cytopathologic analysis of a high-risk endometrial carcinoma". Int. J. Gynecol. Cancer, 1994, 4, 7.

[20] Dunton C. J., Balsam G., McFarland M., Hernandez E.: "Uterine papillary serous carcinoma: a review". Obstet. Gynecol. Surv., 1991, 46, 97.

[21] Gehrig P.A., Groben P.A., Fowler J. R., W. C., Walton L.A., Van Le L.: "Noninvasive papillary serous carcinoma of the endometrium". Obstet. Gynecol., 2001, 97, 153.

[22] DiSaia P., Creasman W. T., Boronow R. C., Blessing J. A.: "Risk factors and recurrent patterns in Stage I endometrial cancer". Am. J. Obstet. Gynecol., 1985, 751, 1009.